Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 442

The DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.

Cardiopulmonary Function and Age-Related Decline Across the Breast Cancer Survivorship Continuum

Open access
Jones, Lee W., Courneya, Kerry S., Mackey, John R., Muss, Hyman B., Pituskin, Edith N., Scott, Jessica M., Hornsby, Whitney E., Coan, April D., Herndon, James E., Douglas, Pamela S., Haykowsky, Mark·2012·Journal of Clinical Oncology

Abstract

Purpose: To evaluate cardiopulmonary function (as measured by peak oxygen consumption [VO 2peak]) across the breast cancer continuum and its prognostic significance in women with metastatic disease. Patients and Methods: Patients with breast cancer representing four cross-sectional cohorts—that is, (1) before, (2) during, and (3) after adjuvant therapy for nonmetastatic disease, and (4) during therapy in metastatic disease—were studied. A cardiopulmonary exercise test (CPET) with expired gas analysis was used to assess VO 2peak. A Cox proportional hazards model was used to estimate the risk of death according to VO 2peak category (< 15.4 v ≥ 15.4 mL · kg−1 · min−1) with adjustment for clinical factors. Results: A total of 248 women (age, 55 ± 8 years) completed a CPET. Mean VO 2peak was 17.8 ± a standard deviation of 4.3 mL · kg−1 · min−1, the equivalent of 27% ± 17% below age-matched healthy sedentary women. For the entire cohort, 32% had a VO 2peak less than 15.4 mL · kg−1 · min−1—the VO 2peak required for functional independence. VO 2peak was significantly different across breast cancer cohorts for relative (mL · kg−1 · min−1) and absolute (L · min−1) VO 2peak (P = .017 and P < .001, respectively); VO 2peak was lowest in women with metastatic disease. In patients with metastatic disease (n = 52), compared with patients achieving a VO 2peak ≤ 1.09 L · min−1, the adjusted hazard ratio for death was 0.32 (95% CI, 0.16 to 0.67, P = .002) for a VO 2peak more than 1.09 L · min−1. Conclusion: Patients with breast cancer have marked impairment in VO 2peak across the entire survivorship continuum. VO 2peak may be an independent predictor of survival in metastatic disease.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1200/jco.2011.39.9014

Cites

48 of 48 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 48 references

Cited by

See all 442

Metadata

Authors
Jones, L. W., Courneya, K. S., Mackey, J. R., Muss, H. B., Pituskin, E. N., Scott, J. M., Hornsby, W. E., Coan, A. D., Herndon, J. E., Douglas, P. S., & Haykowsky, M.
Venue
Journal of Clinical Oncology
Published
2012-07-10
Volume
30
Issue
20
Pages
2530-2537
ISSN
  • 0732-183X (ISSN-L)
  • 1527-7755
OpenAlex
W2101046684
Cited by
442
References
48
FWCI
55.75
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Cardiopulmonary Function and Age-Related Decline Across the Breast Cancer Survivorship Continuum. https://app.cochat.ai/papers/10.1200/jco.2011.39.9014
The paper
Jones, L. W., Courneya, K. S., Mackey, J. R., Muss, H. B., Pituskin, E. N., Scott, J. M., Hornsby, W. E., Coan, A. D., Herndon, J. E., Douglas, P. S., & Haykowsky, M. (2012). Cardiopulmonary Function and Age-Related Decline Across the Breast Cancer Survivorship Continuum. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2011.39.9014

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.